newdrugapprovals.org
BAYER- sPRM (BAY 1002670) Vilaprisan is a novel oral progesterone receptor modulator that holds the promises of long-term treatment of patients with symptomatic uterine fibroids
str is available in this link 20,20,21,21,21-pentafluoro-17-hydroxy-11β-[4- (methanesulfonyl)phenyl]-19-nor-17α-pregna-4,9-dien-3-one progesterone receptor antagonist BAY 1002670, vilaprisan 12621…